Searching for novel antimicrobial agents still represents a current topic in medicinal chemistry. In this study, the synthesis and analytical data of eighteen salicylanilide esters with 4-(trifluoromethyl)benzoic acid are presented. They were assayed in vitro as potential antimycotic agents against eight fungal strains, along with their parent salicylanilides. The antifungal activity of the presented derivatives was not uniform and moulds showed a higher susceptibility with minimum inhibitory concentrations (MIC) ≥ 0.49 µmol/L than yeasts (MIC ≥ 1.95 µmol/L). However, it was not possible to evaluate a range of 4-(trifluoromethyl)benzoates due to their low solubility. In general, the most active salicylanilide was N-(4-bromophenyl)-4-chloro-2-hydroxybenzamide and among esters, the corresponding 2-(4-bromophenylcarbamoyl)-5-chlorophenyl 4-(trifluoromethyl) benzoate exhibited the lowest MIC of 0.49 µmol/L. However, the esterification of salicylanilides by 4-(trifluoromethyl)benzoic acid did not result unequivocally in a higher antifungal potency.

Department of Inorganic and Organic Chemistry Faculty of Pharmacy Charles University Heyrovského 1203 Hradec Králové 50005 Czech Republic

Zobrazit více v PubMed

Lopez-Martinez R. Candidosis, a new challenge. Clin. Dermatol. 2010;6:178–184. doi: 10.1016/j.clindermatol.2009.12.014. PubMed DOI

Silva S., Negri M., Henriques M., Oliveira R., Williams D.W., Azeredo J. Candida glabrata, Candida parapsilosis and Candida tropicalis: Biology, epidemiology, pathogenicity and antifungal resistance. FEMS Microbiol. Rev. 2012;36:288–305. doi: 10.1111/j.1574-6976.2011.00278.x. PubMed DOI

Morschhäuser J. Regulation of multidrug resistance in pathogenic fungi. Fungal Genet. Biol. 2010;47:94–106. doi: 10.1016/j.fgb.2009.08.002. PubMed DOI

Chandrasekar P. Management of invasive fungal infections: A role for polyenes. J. Antimicrob. Chemother. 2011;66:457–465. doi: 10.1093/jac/dkq479. PubMed DOI

Krátký M., Vinšová J., Buchta V., Horvati K., Bösze S., Stolaříková J. New amino acid esters of salicylanilides active against MDR-TB and other microbes. Eur. J. Med. Chem. 2010;45:6106–6113. PubMed

Krátký M., Vinšová J. Antiviral activity of substituted salicylanilides-a review. Mini-Rev. Med. Chem. 2011;11:956–967. PubMed

Krátký M., Vinšová J. Salicylanilide ester prodrugs as potential antimicrobial agents-a review. Curr. Pharm. Des. 2011;17:3494–3505. doi: 10.2174/138161211798194521. PubMed DOI

Waisser K., Pešina M., Holý P., Pour M., Bureš O., Kuneš J., Klimešová V., Buchta V., Kubanová P., Kaustová J. Antimycobacterial and Antifungal Isosters of Salicylamides. Arch. Pharm. Pharm. Med. Chem. 2003;336:322–335. doi: 10.1002/ardp.200300725. PubMed DOI

Otevrel J., Mandelova Z., Pesko M., Guo J., Kralova K., Sersen F., Vejsova M., Kalinowski D.S., Kovacevic Z., Coffey A., et al. Investigating the Spectrum of Biological Activity of Ring-Substituted Salicylanilides and Carbamoylphenylcarbamates. Molecules. 2010;15:8122–8142. PubMed PMC

Ienacu I.M.C., Lupea A.X., Hadaruga D., Hadaruga N., Popescu I.M. The Antimicrobial Activity and Quantitative Structure-Biological Activity Relationships Evaluation of Some Novel 2-Hydroxybenzamide Derivatives. Rev. Chim. 2008;59:247–250.

Pastor L., García-Domenech R., Gálvez J., Wolski S., García M.D. New antifungals selected by molecular topology. Bioorg. Med. Chem. Lett. 1998;8:2577–2582. doi: 10.1016/S0960-894X(98)00460-0. PubMed DOI

Daidone G., Maggio B., Schillaci D. Salicylanilide and its heterocyclic analogues. A comparative study of their antimicrobial activity. Pharmazie. 1990;45:441–442. PubMed

Kumar A., Narasimhan B., Kumar D. Synthesis, antimicrobial, and QSAR studies of substituted benzamides. Bioorg. Med. Chem. 2007;15:4113–4124. doi: 10.1016/j.bmc.2007.03.074. PubMed DOI

Skála P., Macháček M., Vejsová M., Kubicová L., Kuneš J., Waisser K. Synthesis and antifungal evaluation of Hydroxy-3-phenyl-2H-1,3-benzoxazine-2,4(3H)-diones and their thioanalogs. J. Heterocycl. Chem. 2009;46:873–880. doi: 10.1002/jhet.156. DOI

Sivakumar P.M., Seenivasan S.P., Kumar V., Doble M. Novel 1,3,5-triphenyl-2-pyrazolines as anti-infective agents. Bioorg. Med. Chem. Lett. 2010;20:3169–3172. PubMed

Vinsova J., Imramovsky A., Buchta V., Ceckova M., Dolezal M., Staud F., Jampilek J., Kaustova J. Salicylanilide acetates: Synthesis and antibacterial evaluation. Molecules. 2007;12:1–12. doi: 10.3390/12010001. PubMed DOI PMC

Krátký M., Vinšová J., Buchta V. In vitro antibacterial and antifungal activity of salicylanilide benzoates. Sci. World J. 2012;12 doi: 10.1100/2012/290628. PubMed DOI PMC

Krátký M., Vinšová J., Buchta V. In vitro antibacterial and antifungal activity of salicylanilide pyrazine-2-carboxylates. Med. Chem. 2012;8:732–741. doi: 10.2174/157340612801216346. PubMed DOI

De Vita D., Scipione L., Tortorella S., Mellini P., Di Rienzo B., Simonetti G., D’Auria F.D., Panella S., Cirilli R., Di Santo R., et al. Synthesis and antifungal activity of a new series of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives. Eur. J. Med. Chem. 2012;49:334–342. doi: 10.1016/j.ejmech.2012.01.034. PubMed DOI

Imramovský A., Férriz J.M., Pauk K., Krátký M., Vinšová J. Synthetic route for the preparation of 2-hydroxy-N-[1-(2-hydroxyphenylamino)-1-oxoalkan-2-yl]benzamides. J. Comb. Chem. 2010;12:414–416. doi: 10.1021/cc900168s. PubMed DOI

Crawford F., Hollis S. Topical treatments for fungal infections of the skin and nails of the foot. Cochrane Db. Syst. Rev. . 2007 doi: 10.1002/14651858.CD001434.pub2. PubMed DOI PMC

Norrington F.E., Hyde R.M., Williams S.G., Wotton R. Physicochemical-Activity relations inpractice. 1. Rational and self-consistent data bank. J. Med. Chem. 1975;18:604–607. PubMed

Imramovsky A., Vinsova J., Ferriz J.M., Buchta V., Jampilek J. Salicylanilide esters of N-protected amino acids as novel antimicrobial agents. Bioorg. Med. Chem. Lett. 2009;19:348–351. doi: 10.1016/j.bmcl.2008.11.080. PubMed DOI

Waisser K., Bureš O., Holý P., Kuneš J., Oswald R., Jirásková J., Pour M., Klimešová V., Kubicová L., Kaustová J. Relationship between the structure and antimycobacterial activity of substituted salicylanilides. Arch. Pharm. Pharm. Med. Chem. 2003;336:53–71. doi: 10.1002/ardp.200390004. PubMed DOI

Wood R.D., Welsh W.J., Ekins S., Ai N. Glutamate receptor modulators and therapeutic agents. 2009/0239919. U.S. Patent. 2009 Sep 24;

Clinical and Laboratory Standards Institute (CLSI) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard, Third Edition. CSLI document M27–A3, 3rd ed. Vol. 28 CLSI; Wayne, PA, USA: 2008.

Clinical and Laboratory Standards Institute (CLSI) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. Approved Standard, Second Edition. CSLI document M38–A2, 2nd ed. Vol. 28 CLSI; Wayne, PA, USA: 2008.

2-Hydroxy-N-phenylbenzamides and Their Esters Inhibit Acetylcholinesterase and Butyrylcholinesterase

Design and synthesis of anticancer 1-hydroxynaphthalene-2-carboxanilides with a p53 independent mechanism of action

Sulfadiazine Salicylaldehyde-Based Schiff Bases: Synthesis, Antimicrobial Activity and Cytotoxicity

Antibacterial activity of salicylanilide 4-(trifluoromethyl)-benzoates